Detection of Cerebral Ischemia With a Noninvasive Neurometabolic Optical Monitor

CompletedOBSERVATIONAL
Enrollment

29

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

October 31, 2018

Study Completion Date

May 25, 2022

Conditions
Traumatic Brain InjuryIschemic StrokeIntracerebral HemorrhageSubarachnoid HemorrhageAcute Anoxic Encephalopathy
Interventions
DRUG

Indocyanine Green

ICG will be injected to derive absolute CBF and calibrate the DCS monitor to yield continuous absolute CBF. During each 12-hour monitoring session, for up to 14 days, the ICG will be injected at baseline(0.2 mg/kg,(4), every four hours (or less if signal is stable).

Trial Locations (1)

19104

University of Pennylvania Health System, Philadelphia

All Listed Sponsors
lead

University of Pennsylvania

OTHER

NCT02983786 - Detection of Cerebral Ischemia With a Noninvasive Neurometabolic Optical Monitor | Biotech Hunter | Biotech Hunter